Cliodhna McDonough and Emily Lockey give a UK perspective on the potential pros and cons of the three leading candidates in the COVID-19 vaccine race.
Emily Lockey
Advertisement
Emily Lockey, M.D. is a trainee lawyer at Fieldfisher.
Articles by Emily Lockey
Advertisement
Latest Updated Articles
- COVID-19: Is the Vaccine Race Over?
Published: November 27th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
How are the Drug Pricing Negotiations Impacting Pharma's Relationship with DC?
2
Excellergy Announces Launch with $70 Million Series A Funding Aiming to Advance Pipeline of Trifunctional Effector Cell Response Inhibitors
3
Policy Whiplash in Pharma: Navigating Volatility with Strategic Clarity
4
Evolution of Biotech CFOs
5
